Corporate & Commercial

United States federal law still does not address use of Generative AI, though lawmakers have proposed legislation addressing various issues.
In our previous Generative Artificial Intelligence 101 blog post, we discussed intellectual property infringement as a legal risk of using Generative AI. Today, we jump into a discussion of the various other legal liabilities associated

The utilization of artificial intelligence (“AI”) is becoming ubiquitous across a wide range of industry sectors. The biotech industry is no exception.

AI-driven platforms have become increasingly useful to biotech innovators in many areas including in discovering and developing drugs. For example, a 2022 article by McKinsey & Company estimated that nearly 270 companies have

Much has been written regarding Elon Musk’s criticism of the State of Delaware and the decisions of its courts about him and his many successful business enterprises–and by extension the large number of other businesses impacted by Delaware law. In a broader sense, Musk’s criticism, and that of others, has generated discussion about the perennial

The Securities and Exchange Commission today announced charges against Rimar Capital USA, Inc. (Rimar USA), Rimar Capital, LLC (Rimar LLC), Itai Liptz, and Clifford Boro for making false and misleading statements about Rimar LLC’s purported use of…

More information at SECLaw.com Read the Full Press Release

Have a securities law question? Call New York Securities